Cancer incidence and mortality in the Czech Republic

Klinicka Onkologie

Volumn 23, Issue 5, 2010, Pages 311-324

  Dušek, Ladislav ^a   Muzik J ^a   Gelnarova E ^a   Finek J ^b   Vyzula, R ^c   Abrahamova J ^d  

^a MASARYK UNIVERSITY   (Czech Republic)

^b CHARLES UNIVERSITY   (Czech Republic)

^c MASARYK MEMORIAL CANCER INSTITUTE   (Czech Republic)

^d FAKULTNÍ THOMAYEROVA NEMOCNICE   (Czech Republic)

Author keywords

Cancer epidemiology; Czech Republic; Incidence; Mortality

Indexed keywords

ADULT; ARTICLE; BREAST CANCER; CANCER EPIDEMIOLOGY; CANCER STAGING; COLORECTAL CANCER; CZECH REPUBLIC; EARLY DIAGNOSIS; FEMALE; HUMAN; INCIDENCE; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MORTALITY; NON MELANOMA SKIN CANCER; PREVALENCE; PROSTATE CANCER; SKIN CANCER; SKIN MELANOMA;

ADOLESCENT; ADULT; AGED; CHILD; CHILD, PRESCHOOL; CZECH REPUBLIC; FEMALE; HUMANS; INCIDENCE; INFANT; MALE; MIDDLE AGED; NEOPLASMS; YOUNG ADULT;

EID: 78149305100     PISSN: 0862495X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Ferlay J, Bray F, Pisani P et al. GLOBOCAN 2002: Cancer Incidence, Mortality and Prevalence Worldwide. IARC CancerBase No. 5. Version 2.0. Lyon: IARC 2004. [cited 2010 Sep 22]. Available from: http://globocan.iarc.fr.
2. Ferlay J, Shin HR, Bray F et al. GLOBOCAN 2008. Cancer Incidence and Mortality Worldwide. IARC CancerBase No. 10 Lyon: IARC 2010. (cited 2010 Sep 22]. Available from http://globocan.iarc.fr.
3. Boyle P, Ferlay J. Cancer incidence and mortality in Europe, 2004. Ann Oncol 2005; 16(3): 481-488.
4. Curado MP, Edwards B, Shin HR et al. Cancer Incidence in Five Continents. Vol. IX. IARC Scientific Publications No. 160. Lyon: IARC 2007. [cited 2010 Sep 22]. Available from: http.//ci5.iarc.fr.
5. Ferlay J, Autier P, Boniol M et al. Estimates of the cancer incidence and mortality in Europe in 2006. Ann Oncol 2007; 18(3): 581-592. (Pubitemid 46359643)
6. Dušek L. Czech Cancer Care in Numbers, 2008-2009. Praha: GRADA Publishing 2009.
7. Franco EL, Correa P, Santella RM et al. Role and limitations of epidemiology in establishing a causal association. Semin Cancer Biol 2004; 14(6): 413-426.
8. Berrino F, De Angelis R, Sant M et al. Suraval for eight major cancers and all cancers combined for European adults diagnosed in 1995-1999: results of the EURO-CARE-4 study. Lancet Oncol 2007; 8(9): 773-783.
9. Verdecchia A, Francisci S, Brenner H et al. Recent cancer survival in Europe: a 2000-2002 period analysis of EURO-CARE-4 data. Lancet Oncol 2007; 8(9): 784-796.
10. Brenner H, Gondos A, Arndt V. Recent major progress in long-term cancer patient survival disclosed by modelled period analysis. J Clin Oncol 2007; 25(22): 3274-3280.
11. Coleman MP, Quaresma, M, Berrino F et al. Cancer survival in five continents: a worldwide population-based study (CONCORD). Lancet Oncol 2008; 9(8): 730-756.
12. Ponz de Leon M, Rossi G, di Gregorio C et al. Epidemiology of colorectal cancer: the 21-year experience of a specialised registry. Intern Emerg Med 2007; 2(4): 269-279.
13. Council recommendation of 2 December 2003 on cancer screening (2003/878/EC). Official J Eur Union 2003; L 327/34: 85-89.
14. IARC Working Group on the Evaluation of Cancer-Preventive Strategies. Cervix Cancer Screening. Lyon: IARC 2005.
15. Bray F, Sankila R, Ferlay J et al. Estimates of cancer incidence and mortality in Europe in 1995. Eur J Cancer 2002; 38(1): 99-166.
16. Czech Statistical Office. Demographic data of the Czech Republic and Death Records Database of the Czech Republic [cited 2010 Aug 18]. Available from: http.//www.czso.cz/eng/redakce.nsf/i/population.
17. Czech Statistical Office. Demographic Yearbook of the Czech Republic 2007 [cited 2010 Aug 18]. Available from: http://www.czso.cz
18. Institute of Health Information and Statistics of the Czech Republic (IHIS). National Health Information System (NHIS), Czech National Cancer Registry [cited 2007 Dec 20]. Available from: http://www.uzis.cz/info.php? artide=368&mnu-id=7300
19. Dušek L, Mužík J, Kubásek M et al. Epidemiology of malignant tumours in the Czech Republic [online]. Masaryk University 2005 [cited 2008 Dec 15]. Available from: http://www.svod.cz.
20. Institute of Health Information and Statistics of the Czech Republic (IHIS). Binding instructions of the National Health Information System (NHIS): Czech National Cancer Registry - instruction for the contents of data structure, version 051-20060101/2. Prague, IHIS 2006 [cited 2007 Jun 18]. Available from: http://www.uzis.cz, section IHIS, part Binding instructions.
21. World Health Organization. International statistical classification of diseases and related health problems, 10th revision (ICD-10). Geneve: World Health Organization 1992.
22. Sobin LH, Gospodarowicz MK, Wittekind CH. TNM Classification of Malignant Tumors, 7th ed. Oxford: Wiley-Blackwell 2009.
23. World Health Organization. WHO Statistical Information System. Geneva, Switzerland: WHO Databank [cited 2010 Sep 4]. Available from: http://wwwwho.int/whosis.
24. Comparability and Quality Improvement of European Causes of Death Statistics, EDC DGV/F3 SOC 98 20108-INSERM SC8/Ce'piDc-Final Report. Jully 2001.
25. Percy C, Muir C. The international comparability of cancer mortality data. Results of an international death certificate study Am J Epidemiol 1989; 129(5): 934-946.
26. International Agency for Research on Cancer. Cancer Incidence in Five Continents. IARC Scientific Publication no. 42. Lyon: IARC 1982.
27. Adami HO, Hunter D, Trichopoulos D. Textbook of cancer epidemiology. New York: Oxford University Press 2002.
28. Waterhouse J, Muir C, Correa P et al. Cancer Incidence in Five Continents. Vol. III. IARC Scientific Publications No. 15. Lyon: IARC 1976.
29. Karim-Kos HE, de Vries E, Soerjomataram I et al. Recent trends of cancer in Europe: a combined approach of incidence, survival and mortality for 17 cancer sites since the 1990s. Eur J Cancer 2008; 44(10): 1345-1389.
30. Frič P. The use of haemoccult test in the early diagnosis of colerectal cancer - experience from six pilot studies in Czechoslovakia. In: Hardcastle JV (ed). Haemoccult screening for the early detection of colorectal cancer. Stuttgart: Schattauer 1986: 73-74.
31. Zavoral M, Suchánek S, Závada F et al. Colorectal cancer screening in Europe. World J Gastroenterol 2009, 15(47): 5907-5915.
32. Mandel JS, Bond JH, Church TR et al. Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study N Engl J Med 1993; 328(19): 1365-1371.
33. Hardcastle JD, Chamberlain JO, Robinson MH et al. Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet 1996; 348(9040): 1472-1477.
34. Flannery JT, Boice JD Jr, Devesa SS et al. Cancer registration in Connecticut and the study of multiple primary cancers, 1935-1982. Natl Cancer Inst Monogr 1985; 68: 13-24
35. Anderson WF, Guyton KZ, Hiatt RA et al. Colorectal cancer screening for persons at average risk. J Natl Cancer Inst 2002; 94(15): 1126-1133.
36. Winawer S, Fletcher R, Rex D et al. Colorectal cancer screening and surveillance: clinical guidelines and rationale-Update based on new evidence. Gastroenterology 2003, 124(2): 544-560.
37. Boffetta P, McLaughlin JK, la Vecchia C et al. 'Environment' in cancer causation and etiological fraction: limitations and ambiguities. Carcinogenesis 2007; 28(5): 913-915.
38. Wild CP. Environmental exposure measurement in cancer epidemiology. Mutagenesis 2009; 24(2): 117-125.
39. Engholm G, Ferlay J, Christensen N et al. NORDCAN: Cancer Incidence, Mortality, Prevalence and Prediction in the Nordic Countries, Version 3.5. Association of the Nordic Cancer Registries. Danish Cancer Society 2009 [cited 2010 Sep 24]. Available from: http://www.ancr.nu.